SBFM · Sunshine Biopharma Inc.
$1.67
-0.04 (-2.34%)
At close · Jul 24
Market Cap
$8.31M
Shares
5.01M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$2,000,000
as of 2023-01-19
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-07-20 | $4,000,000 | — | — | — | 8-K , filed 2026-07-20 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-04-03 |
| 2024-12-31 | $3,139,651 | 10-K, filed 2026-04-03 |
| 2023-12-31 | $541,143 | 10-K, filed 2025-04-01 |